New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
06:36 EDTCBSTCubist upgraded to Hold from Sell at Cantor
Cantor upgraded Cubist to Hold citing the playing out of negative catalysts following the company's Q4 results and 2013 outlook. The firm raised its price target for shares to $38 from $37.
News For CBST From The Last 14 Days
Check below for free stories on CBST the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
08:08 EDTCBSTCubist potential strategic buyer may be willing to pay $95 or more, says Cowen
Cowen noted Cubist's Cubicin sales were light during the quarter as management cited seasonality. The firm believes the miss is a non-event and sees value creation for shareholders entering at these levels. Cowen continues to believe Cubist should and will be acquired by a strategic buyer with a U.S. and International hospital sales force presence and could potentially pay $95 or more for the company. Shares are Outperform rated with a $80 price target.
April 22, 2014
18:09 EDTCBSTCubist sees FY14 revenue $1.19B-$1.28B, consensus $1.25B
Subscribe for More Information
16:02 EDTCBSTCubist reports Q1 EPS 10c, consensus 0.0c
Subscribe for More Information
15:32 EDTCBSTNotable companies reporting after market close
Subscribe for More Information
April 21, 2014
08:35 EDTCBSTCubist submits Ceftolozane/tazobactam NDA to FDA
Subscribe for More Information
07:56 EDTCBSTCubist price target raised to $90 from $80 at Leerink
Subscribe for More Information
April 18, 2014
13:32 EDTCBSTCubist announces voluntarily recalling one Cubicin lot
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use